Aristro Capital Markets Ltd.
You Are On :   Home  |  Equity  |   Company Profile  |  Board Meetings
 
Equity
Equity Analysis
Price
Volume
Analysis
News Analysis
Corporate Action
Other Market
Company Profile
Board Meetings
Board Meetings
Novelix Pharmaceuticals Ltd.
 
BSE Code 536565
ISIN Demat INE314I01036
Book Value (Rs.) 23.29
NSE Code NA
Dividend Yield  % 0.00
Market Cap  (Rs. Mn) 1178.65
TTM PE (x) 64.55
TTM EPS (Rs.) 0.87
Face Value (Rs.) 10  
Source DateBoard Meeting DateDetails
09-Feb-2026 12-Feb-2026 Quarterly Results
08-Dec-2025 11-Dec-2025 Preferential Issue of shares & Inter alia, to consider and approve:- 1) To consider and if thought fit, approve the issuance of securities of the Company on a preferential basis in accordance with the Companies Act, 2013 read with the rules notified thereunder, each as amended, and the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended and such other acts, rules and regulations, as may be applicable, subject to any regulatory/ statutory approvals, as may be required and the approval of the shareholders of the Company. 2) To adopt and approve the Draft Notice of Extra Ordinary General Meeting of the Company. 3) To fix the day, date, time and venue of Extra Ordinary General Meeting of the Company. 4) To appoint Scrutinizer for conducting E- voting process for Extra Ordinary General Meeting. 5) Any other Matter with the permission of the chair.
10-Nov-2025 13-Nov-2025 Quarterly Results
07-Aug-2025 14-Aug-2025 Quarterly Results & A.G.M.
24-Jun-2025 24-Jun-2025 Inter alia, to consider and approve the conversion of Warrants into Equity Shares of the Company.
20-May-2025 27-May-2025 Audited Results
09-Apr-2025 12-Apr-2025 Inter alia, to consider and approve:- 1. To consider and approve the convening of an EGM for seeking shareholder approval for the confirmation of appointment of Mr. Laxman Samala as Non-Executive Independent Director of the Company. 2. To appoint a scrutinizer for to scrutinize the voting process for the upcoming EGM. 3. Any other item with the approval of the chairman.
07-Feb-2025 12-Feb-2025 Quarterly Results
11-Nov-2024 13-Nov-2024 Quarterly Results & Inter-alia to discuss the following: 1. To take note of the Certificate of Whole Time Director & Chief Financial Officer of the Company for the quarter and half year ended 30th September 2024. 2. To consider and approve the appointment of the Director of the Company. 3. Any other item with the approval of the chairman.
11-Oct-2024 21-Oct-2024 Issue of Warrants (Revised)
close X

Download Client Registration Documents

Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do's & Don't's) in Vernacular Language :
Assamese Bengali Gujarati Hindi Kanada Kashmiri Konkani Malyalam Marathi Oriya Punjabi Sindhi Tamil Telegu Urdu

NOTE : " This document is a translated version of the client registration documents in English and is being provided in vernacular language to facilitate better understanding by the investors. In case of any ambiguity, the contents of the English version would prevail. "

Client Registration Documents in Vernacular Languages

Member: NSE CAPITAL MARKET: INB231498438 | NSE FUTURE & OPTION: INF231498438 | BSE CAPITAL MARKET: INB011498434 | BSE FUTURE MARKET: INF011498434 | DP REGN No.:IN-DP-CDSL-704-2013 | Single SEBI Registration nos.: NSE & BSE: INZ000219238 | DP CDSL: IN-DP-407-2019
Attention Investor: Update your mobile number and email id with your stock broker.
ATTENTION INVESTORS :
"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
ATTENTION INVESTORS :
"Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day...................... issued in the interest of investors.
ATTENTION INVESTORS :
"No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Home| About Us | Services | Login | Research | Online Trading | Customer Support | Useful links | SEBI SCORE | Contact Us | Investor Charter | Share Links:  
Terms & Conditions |Disclaimer | Privacy Policy |Policy & Procedure | Feedback | Open An Account | Downloads |Customer Desk |Policy |Site Map |Segregation and Monitoring of Collateral
NSE | BSE | SEBI | NSDL | NCDEX | CDSL | MCX | NMCE | MCX-SX | RBI | Do & Don'ts | CDSL Circular | CDSL e-Voting | Rights & Obligations | Risk Disclousre Document
Details of Authorised Persons | Basic Details | SMART ODR | Policy on Handling of GTC Orders | Saral Account opening form | Rights and Obligation for DP
QR Code for DP | QR Code for Stock Broker | ARISTRO MGT7 | CSR Policy Aristro
Copyright Aristro Capital Markets Ltd. All Rights Reserved.
Designed, Developed & Content Powered By  Accord Fintech Pvt. Ltd.